The Enterprise Value as of December 2025 (TTM) for CStone Pharmaceuticals (CSPHF) is 7.45B

According to CStone Pharmaceuticals’s latest financial reports and current stock price. The company's current Enterprise Value is 7.45B. This represents a change of 172.08% compared to the average of 2.74B of the last 4 quarters.

CStone Pharmaceuticals (CSPHF) Historical Enterprise Value (quarterly & annually)

How has CSPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of CStone Pharmaceuticals over the last ten years is 6.79B. The current 7.45B Enterprise Value has changed 10.88% with respect to the historical average. Over the past ten years (40 quarters), CSPHF's Enterprise Value was at its highest in in the June 2021 quarter at 14.06B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

CStone Pharmaceuticals (CSPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CStone Pharmaceuticals Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CStone Pharmaceuticals (CSPHF) Average Enterprise Value

How has CSPHF Enterprise Value performed in the past?

The current Enterprise Value of CStone Pharmaceuticals (CSPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CStone Pharmaceuticals (CSPHF) Enterprise Value vs. Peers

How is CSPHF’s Enterprise Value compared to its peers?

CStone Pharmaceuticals’s Enterprise Value is greater than Kuros Biosciences AG (1.19B), greater than Mesoblast Limited (2.23B), less than Ascletis Pharma Inc. (10.36B), less than PeptiDream Inc. (181.74B), greater than Pharma Mar, S.A. (1.35B), greater than Oxford Nanopore Technologies plc (1.08B), less than China Traditional Chinese Medicine Holdings Co. Limited (9.85B), less than SanBio Company Limited (124.31B), greater than Ryman Healthcare Limited (4.59B), greater than Neuren Pharmaceuticals Limited (2.45B),

Build a custom stock screener for CStone Pharmaceuticals (CSPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CStone Pharmaceuticals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CStone Pharmaceuticals (CSPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CStone Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.